Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022
Author(s): Guiomar Mendieta Added: 1 year ago

Vascular Disease and Surgery

Heart Failure
ESC 22 Late-breaker Discussion: The ADVOR Trial
Author(s): Harriette Van Spall , Wilfried Mullens Added: 1 year ago
SC Congress 22 — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) sat down with the principal investigator of the ADVOR trial (NCT03505788), Prof Wilfried Mullens (Hospital Oost-Limburg (ZOL), BE) to talk about the trial design and practical consideration in light of the new data. ADVOR, a multi-center, randomized, double-blind clinical trial assessed the diuretic effects of… View more

Heart Failure
View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What are the take-home messages from ESC 22 and what are the implications for practice? In this short wrap-up video of ESC 22, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) review the most impactful hot line and late-breaking trials of ESC Congress 2022. Trials covered in detail include: On clinical judgement after PCI 00:35:27:REVIVED-BCIS2: Study of… View more

Anticoagulation

Standards & Guidelines